jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Aug. 20, 2021

Jan. 27, 2025

jRCT2031210266

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer

Ichioka Shigeru

Saitama Medical University Hospital

38 Morohongo Moroyama-machi, Iruma-gun

+81-492-76-1299

ichioka2006@yahoo.co.jp

Tomioka Hideki

FunPep Co., Ltd.

Office for University-Industry Collaboration Bldg. A, 5F No.509, Osaka University 2-1 Yamadaoka, Suita, Osaka

+81-6-6369-7957

htomioka@funpep.co.jp

Complete

Aug. 02, 2021

120

Interventional

randomized controlled trial

double blind

placebo control

parallel assignment

treatment purpose

Patients must have a wound requiring wound bed preparation in advance of planned surgical closure (including suturing, grafts or flaps)

Presence of untreated ulcer infection (redness, swelling, pus, foul odor, fever)

18age old over
85age old not

Both

skin ulcer

SR-0379 or placebo spray

The days to simple surgical intervention (ncluding suturing, grafts or flaps)

FunPep Co., Ltd.
Saitama Medical University Hospital Clinical Trial
38 Morohongo Moroyama-machi, Iruma-gun, Saitama

+81-49-276-1454

tikens@saitama-med.ac.jp
Approval

July. 01, 2021

No

none

History of Changes

No Publication date
4 Jan. 27, 2025 (this page) Changes
3 Mar. 03, 2023 Detail Changes
2 Mar. 10, 2022 Detail Changes
1 Aug. 20, 2021 Detail